<?xml version="1.0" encoding="UTF-8"?>
<ref id="B163-vaccines-08-00224">
 <label>163.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gritti</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Raimondi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Ripamonti</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Riva</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Landi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Alborghetti</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Frigeni</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Damiani</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mic√≤</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Fagiuoli</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support</article-title>
  <source>medRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1101/2020.04.01.20048561</pub-id>
 </element-citation>
</ref>
